Consolidation and expansion of the DOTS programme in Kyrgyzstan by providing access to diagnostics and treatment of drug-resistant tuberculosis.

About the project

photo from a presentation
One of the slides of the presentation made on the 2012 World TB Day in Bishkek. The caption of the photo reads: "In Kyrgyzstan 454 persons died of tuberculosis in 2012".

Overall goal of the project is to reduce the burden of tuberculosis in Kyrgyzstan by consolidating the Directly Observed Treatment, short-course (DOTS) framework, the best TB treatment methodology so far. The project will help strengthen national institutional capacities to reduce the incidence and mortality rate of tuberculosis. Currently, the programme is in its second implementation phase which started in 2013. The programme is funded by the Global Fund to Fight AIDS, TB and Malaria.

Expected results

  • Improved legal and regulatory basis for TB service delivery;
  • Strong management, coordination, monitoring and evaluation of the National TB Programme;
  • Strong network of TB laboratories;
  • Improved management of TB cases;
  • Improved Primary Health Care Involvement in TB control;
  • Enhanced infection control in the TB facilities at the regional level;
  • Increased capacity of the NTP and within specialized TB services and other health care providers (including primary health care providers and health care personnel in prisons) to diagnose and treat TB and to manage MDR-TB countrywide;
  • Better diagnosis of drug-resistant TB through routine drug resistance testing
  • Strong drug supply system;
  • Improved treatment of drug-resistant tuberculosis cases;
  • Scaling-up patient support program for drug-resistant tuberculosis patients;
  • Raised awareness of target population about TB and reduced stigma.

What we have accomplished so far



  • Since its inception in 2011 until December 2013 the programme demonstrated improvement in the impact and outcome of TB response through the achievement of the following indicators:
  • The treatment success rate among multi-drug resistant (MDR) patients has improved from 42,2% in 2012 to 53,7% in 2013
  • Improved case detection of new smear positive TB cases: the relevant program indicator for the first period of 2013 exceeded the planned targets and reached 106%.
  • The programme reached 3407 patients with social support during in-patient and outpatient phases of multi-drug resistant TB treatment;
  • 1137 MDR patients with multidrug resistant tuberculosis were being treated with the second line drugs procured for the grant’s funds 
  • 2869 patients were counseled and educated on the issues of multi-drug resistant TB
  • 1139 medical staff were trained locally as well as 12- internationally with the support of the grant funds

Who finances it?

Donor Amount (USD)
The Global Fund to Fight AIDS, TB and Malaria (2011-2015)
19,513,207

Delivery

Year Amount (USD)
2012
2,331,024
2011 3,581,902
Project Overview
Status
Active
Project Start Date
1 January 2011
Estimated End Date
December 31, 2013
Geographic Coverage
Country-wide
Focus Area
HIV, TB and Malaria
Project Officer
Janyl Rakhmanova
Partners
Kyrgyz Republic Ministry of Healtcare, NGOs
Download related documents